GAPDH and benign prostatic hyperplasia: After quantification of ZFP91 abundance in BPH and control samples using GAPDH levels as a reference (Fig. 3), differences in ZFP91 protein levels between two groups were found to be insignificant, which stands in contrast to the mRNA levels differences.